NR 546 ADVANCED PSYCHOPHARMACOLOGY
FINAL EXAM PREP COMPREHENSIVE Q&AS
WITH DETAILED RATIONALES
This premium psychopharmacology study resource features
comprehensive multiple-choice questions, correct answers, and
highly detailed rationales covering advanced neurobiology and
clinical practice. It delivers an exhaustive review of neurotransmitter
pathways, mechanism profiles, monitoring protocols, and drug
interactions essential for mastering complex psychiatric-mental
health nurse practitioner exams. Designed for maximum scannability
and long-term retention, this question bank serves as the ultimate
diagnostic and preparation tool for high-stakes clinical assessments.
Question 1
Topic: Dopamine Pathways
Which dopamine pathway is primarily responsible for the positive
symptoms of schizophrenia, such as hallucinations and delusions, and
serves as the primary target for first-generation antipsychotics?
• A. Nigrostriatal pathway
• B. Mesolimbic pathway
• C. Mesocortical pathway
• D. Tuberoinfundibular pathway
Answer: B
Rationale: Hyperactivity of dopamine in the mesolimbic pathway
mediates the positive symptoms of schizophrenia. Blockade of
,dopamine D2 receptors in this pathway is the mechanism by which
antipsychotic medications reduce these symptoms.
Question 2
Topic: Dopamine Pathways
Hypoactivity in which dopamine pathway is thought to mediate the
negative, cognitive, and affective symptoms of schizophrenia?
• A. Mesolimbic pathway
• B. Nigrostriatal pathway
• C. Mesocortical pathway
• D. Tuberoinfundibular pathway
Answer: C
Rationale: The mesocortical pathway projects from the ventral
tegmental area to the prefrontal cortex. A deficit of dopamine in this
pathway is heavily implicated in the cognitive deficits, negative
symptoms (e.g., avolition, alogia), and affective symptoms of
schizophrenia.
Question 3
Topic: Dopamine Pathways
A patient taking a high-potency first-generation antipsychotic develops
severe tremors, rigidity, and bradykinesia. Antipsychotic-induced blockade
of D2 receptors in which pathway causes these symptoms?
• A. Mesolimbic pathway
• B. Nigrostriatal pathway
• C. Mesocortical pathway
• D. Tuberoinfundibular pathway
,Answer: B
Rationale: The nigrostriatal pathway controls motor movement via the
basal ganglia. When D2 receptors in this pathway are blocked, it
mimics Parkinson's disease, leading to extrapyramidal symptoms
(EPS) such as tremor, rigidity, and slowness.
Question 4
Topic: Dopamine Pathways
A female patient taking risperidone complains of amenorrhea and
galactorrhea. Blockade of D2 receptors in which dopamine pathway
accounts for these adverse effects?
• A. Mesolimbic pathway
• B. Mesocortical pathway
• C. Nigrostriatal pathway
• D. Tuberoinfundibular pathway
Answer: D
Rationale: Dopamine acts as a prolactin-inhibiting factor in the
tuberoinfundibular pathway. Blocking D2 receptors here removes this
inhibitory tone, causing an increase in prolactin levels
(hyperprolactinemia), which can lead to galactorrhea, amenorrhea,
and gynecomastia.
Question 5
Topic: Serotonin Pathways
Where are the vast majority of serotonin-producing neuronal cell bodies in
the central nervous system located?
• A. Locus coeruleus
• B. Raphe nuclei
, • C. Substantia nigra
• D. Nucleus basalis of Meynert
Answer: B
Rationale: The raphe nuclei, located throughout the brainstem,
contain the primary clusters of serotonergic cell bodies that project
widely across the entire central nervous system to regulate mood,
sleep, appetite, and pain.
Question 6
Topic: Norepinephrine Pathways
The ascending noradrenergic projections that regulate attention, alertness,
arousal, and mood originate primarily from which area of the brain?
• A. Nucleus accumbens
• B. Locus coeruleus
• C. Ventral tegmental area
• D. Hypothalamus
Answer: B
Rationale: The locus coeruleus, located in the pons, is the principal
site for norepinephrine synthesis in the brain. Its extensive
projections modulate wakefulness, attention, anxiety, and stress
responses.
Question 7
Topic: Mechanism of Action: SSRIs
What is the primary mechanism of action of Selective Serotonin Reuptake
Inhibitors (SSRIs)?
• A. Direct agonism of postsynaptic 5-HT1A receptors
• B. Competitive inhibition of Monoamine Oxidase Type A
FINAL EXAM PREP COMPREHENSIVE Q&AS
WITH DETAILED RATIONALES
This premium psychopharmacology study resource features
comprehensive multiple-choice questions, correct answers, and
highly detailed rationales covering advanced neurobiology and
clinical practice. It delivers an exhaustive review of neurotransmitter
pathways, mechanism profiles, monitoring protocols, and drug
interactions essential for mastering complex psychiatric-mental
health nurse practitioner exams. Designed for maximum scannability
and long-term retention, this question bank serves as the ultimate
diagnostic and preparation tool for high-stakes clinical assessments.
Question 1
Topic: Dopamine Pathways
Which dopamine pathway is primarily responsible for the positive
symptoms of schizophrenia, such as hallucinations and delusions, and
serves as the primary target for first-generation antipsychotics?
• A. Nigrostriatal pathway
• B. Mesolimbic pathway
• C. Mesocortical pathway
• D. Tuberoinfundibular pathway
Answer: B
Rationale: Hyperactivity of dopamine in the mesolimbic pathway
mediates the positive symptoms of schizophrenia. Blockade of
,dopamine D2 receptors in this pathway is the mechanism by which
antipsychotic medications reduce these symptoms.
Question 2
Topic: Dopamine Pathways
Hypoactivity in which dopamine pathway is thought to mediate the
negative, cognitive, and affective symptoms of schizophrenia?
• A. Mesolimbic pathway
• B. Nigrostriatal pathway
• C. Mesocortical pathway
• D. Tuberoinfundibular pathway
Answer: C
Rationale: The mesocortical pathway projects from the ventral
tegmental area to the prefrontal cortex. A deficit of dopamine in this
pathway is heavily implicated in the cognitive deficits, negative
symptoms (e.g., avolition, alogia), and affective symptoms of
schizophrenia.
Question 3
Topic: Dopamine Pathways
A patient taking a high-potency first-generation antipsychotic develops
severe tremors, rigidity, and bradykinesia. Antipsychotic-induced blockade
of D2 receptors in which pathway causes these symptoms?
• A. Mesolimbic pathway
• B. Nigrostriatal pathway
• C. Mesocortical pathway
• D. Tuberoinfundibular pathway
,Answer: B
Rationale: The nigrostriatal pathway controls motor movement via the
basal ganglia. When D2 receptors in this pathway are blocked, it
mimics Parkinson's disease, leading to extrapyramidal symptoms
(EPS) such as tremor, rigidity, and slowness.
Question 4
Topic: Dopamine Pathways
A female patient taking risperidone complains of amenorrhea and
galactorrhea. Blockade of D2 receptors in which dopamine pathway
accounts for these adverse effects?
• A. Mesolimbic pathway
• B. Mesocortical pathway
• C. Nigrostriatal pathway
• D. Tuberoinfundibular pathway
Answer: D
Rationale: Dopamine acts as a prolactin-inhibiting factor in the
tuberoinfundibular pathway. Blocking D2 receptors here removes this
inhibitory tone, causing an increase in prolactin levels
(hyperprolactinemia), which can lead to galactorrhea, amenorrhea,
and gynecomastia.
Question 5
Topic: Serotonin Pathways
Where are the vast majority of serotonin-producing neuronal cell bodies in
the central nervous system located?
• A. Locus coeruleus
• B. Raphe nuclei
, • C. Substantia nigra
• D. Nucleus basalis of Meynert
Answer: B
Rationale: The raphe nuclei, located throughout the brainstem,
contain the primary clusters of serotonergic cell bodies that project
widely across the entire central nervous system to regulate mood,
sleep, appetite, and pain.
Question 6
Topic: Norepinephrine Pathways
The ascending noradrenergic projections that regulate attention, alertness,
arousal, and mood originate primarily from which area of the brain?
• A. Nucleus accumbens
• B. Locus coeruleus
• C. Ventral tegmental area
• D. Hypothalamus
Answer: B
Rationale: The locus coeruleus, located in the pons, is the principal
site for norepinephrine synthesis in the brain. Its extensive
projections modulate wakefulness, attention, anxiety, and stress
responses.
Question 7
Topic: Mechanism of Action: SSRIs
What is the primary mechanism of action of Selective Serotonin Reuptake
Inhibitors (SSRIs)?
• A. Direct agonism of postsynaptic 5-HT1A receptors
• B. Competitive inhibition of Monoamine Oxidase Type A
